Regeneron Pharmaceuticals (REGN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Kevin Travers16:19 ET
Friday? More Like Grinch Day | Wall Street Today
Kevin Travers16:02 ET
Regeneron Expands Eye Care Focus With Oxular Buyout
Seeking Alpha13:12 ET
Santa Claus Came Without Rallying the Troops | Live Stock
Kevin TraversJan 3 10:45 ET
Regeneron Pharmaceuticals' (NASDAQ:REGN) Investors Will Be Pleased With Their Decent 89% Return Over the Last Five Years
Yahoo FinanceDec 31, 2024 07:00 ET
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Kevin TraversDec 30, 2024 11:01 ET

Comments

韭菜变主力

Dec 31 16:47

$Regeneron Pharmaceuticals (REGN.US)$Nice. It’s quiet here and just broke the steep down trend.

10xStockPicks

Dec 29, 2024 17:56

Roaring Kitty New Years Eve Party, New Investment Idea For 2025

It is rumored Keith Gill will make new investments in 2025 potentially in the health care sector, based on the new Trump administration & RFK looking out for the health of Americans. Rumor is Keith is attending a New Years Eve party with a friend who's father take a statin alternative drug called NEXLIZET made by $Esperion Therapeutics (ESPR.US)$
This information comes from a friend of CNBC Jim Cramer who is also statin intolerant an...

1

10xStockPicks

Dec 15, 2024 18:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

10

2

4

10xStockPicks

Dec 14, 2024 21:19

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...